No Cover Image

Journal article 1066 views 1934 downloads

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G. Eliaschewitz, Denise R. Franco, Ole K. Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D. Pedersen, Cees J. Tack, Mette Thomsen, Tina Vilsbøll, Mark L. Warren, Steve Bain Orcid Logo

New England Journal of Medicine, Volume: 381, Issue: 9, Pages: 841 - 851

Swansea University Author: Steve Bain Orcid Logo

  • 51010.pdf

    PDF | Version of Record

    Copyright © 2019 Massachusetts Medical Society. Reprinted with permission

    Download (239.22KB)

Check full text

DOI (Published version): 10.1056/nejmoa1901118

Published in: New England Journal of Medicine
ISSN: 0028-4793 1533-4406
Published: Massachusetts Medical Society 2019
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa51010
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2019-07-04T14:55:48Z
last_indexed 2023-01-11T14:27:39Z
id cronfa51010
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-12-02T19:01:17.5690089</datestamp><bib-version>v2</bib-version><id>51010</id><entry>2019-07-04</entry><title>Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-07-04</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>New England Journal of Medicine</journal><volume>381</volume><journalNumber>9</journalNumber><paginationStart>841</paginationStart><paginationEnd>851</paginationEnd><publisher>Massachusetts Medical Society</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0028-4793</issnPrint><issnElectronic>1533-4406</issnElectronic><keywords/><publishedDay>29</publishedDay><publishedMonth>8</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-08-29</publishedDate><doi>10.1056/nejmoa1901118</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T19:01:17.5690089</lastEdited><Created>2019-07-04T11:29:42.7448228</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Mansoor</firstname><surname>Husain</surname><order>1</order></author><author><firstname>Andreas L.</firstname><surname>Birkenfeld</surname><order>2</order></author><author><firstname>Morten</firstname><surname>Donsmark</surname><order>3</order></author><author><firstname>Kathleen</firstname><surname>Dungan</surname><order>4</order></author><author><firstname>Freddy G.</firstname><surname>Eliaschewitz</surname><order>5</order></author><author><firstname>Denise R.</firstname><surname>Franco</surname><order>6</order></author><author><firstname>Ole K.</firstname><surname>Jeppesen</surname><order>7</order></author><author><firstname>Ildiko</firstname><surname>Lingvay</surname><order>8</order></author><author><firstname>Ofri</firstname><surname>Mosenzon</surname><order>9</order></author><author><firstname>Sue D.</firstname><surname>Pedersen</surname><order>10</order></author><author><firstname>Cees J.</firstname><surname>Tack</surname><order>11</order></author><author><firstname>Mette</firstname><surname>Thomsen</surname><order>12</order></author><author><firstname>Tina</firstname><surname>Vilsb&#xF8;ll</surname><order>13</order></author><author><firstname>Mark L.</firstname><surname>Warren</surname><order>14</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>15</order></author></authors><documents><document><filename>51010__16510__4cd4201df80e4682845b84b0ebe203f0.pdf</filename><originalFilename>51010.pdf</originalFilename><uploaded>2020-02-03T12:24:43.3704210</uploaded><type>Output</type><contentLength>244958</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2019-12-11T00:00:00.0000000</embargoDate><documentNotes>Copyright &#xA9; 2019 Massachusetts Medical Society. Reprinted with permission</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2022-12-02T19:01:17.5690089 v2 51010 2019-07-04 Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2019-07-04 BMS Journal Article New England Journal of Medicine 381 9 841 851 Massachusetts Medical Society 0028-4793 1533-4406 29 8 2019 2019-08-29 10.1056/nejmoa1901118 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2022-12-02T19:01:17.5690089 2019-07-04T11:29:42.7448228 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Mansoor Husain 1 Andreas L. Birkenfeld 2 Morten Donsmark 3 Kathleen Dungan 4 Freddy G. Eliaschewitz 5 Denise R. Franco 6 Ole K. Jeppesen 7 Ildiko Lingvay 8 Ofri Mosenzon 9 Sue D. Pedersen 10 Cees J. Tack 11 Mette Thomsen 12 Tina Vilsbøll 13 Mark L. Warren 14 Steve Bain 0000-0001-8519-4964 15 51010__16510__4cd4201df80e4682845b84b0ebe203f0.pdf 51010.pdf 2020-02-03T12:24:43.3704210 Output 244958 application/pdf Version of Record true 2019-12-11T00:00:00.0000000 Copyright © 2019 Massachusetts Medical Society. Reprinted with permission true eng
title Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
spellingShingle Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steve Bain
title_short Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
title_full Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
title_fullStr Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
title_full_unstemmed Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
title_sort Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Mansoor Husain
Andreas L. Birkenfeld
Morten Donsmark
Kathleen Dungan
Freddy G. Eliaschewitz
Denise R. Franco
Ole K. Jeppesen
Ildiko Lingvay
Ofri Mosenzon
Sue D. Pedersen
Cees J. Tack
Mette Thomsen
Tina Vilsbøll
Mark L. Warren
Steve Bain
format Journal article
container_title New England Journal of Medicine
container_volume 381
container_issue 9
container_start_page 841
publishDate 2019
institution Swansea University
issn 0028-4793
1533-4406
doi_str_mv 10.1056/nejmoa1901118
publisher Massachusetts Medical Society
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2019-08-29T04:02:44Z
_version_ 1763753238810591232
score 11.012678

Similar Items